To explore whether a protein-based biomarker diagnostic tool may be useful to detect pathophysiological alterations underlying NPS, we determined two optimal diagnostic models including three proteins each: one without AD pathology status (IDS + RELN + SH3L2) and the second considering AD status (MIME + IDS + K22E + AD). The gene discussed is RELN; the disease is Alzheimer disease.